Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2002
PHARMAC documents that matched your search:
2002-11 PTAC Minutes (Metronidazole Gel)
(2 pages, 8 KB)
2002/11/01
The Committee first considered an application from St Ives Medical to list the Orion brand of metronidazole gel 0.5%, 10g on the Pharmaceutical Schedule at it s 22…
Letter to British Medical Journal: Is Celebrex's relative GI safety overstated?
(9 pages, 1176 KB)
2002/10/14
Is Celebrex’s relative GI safety is overstated? The editorial by Roger Jones makes important points about the limitations of the meta-analysis by Jon Deeks and colleagues2 for celecoxib. However, we also note that the Deeks meta -analysis does not account for the 12-15-month data for the CLASS study compiled by the FDA3 4 and cited by Peter Juni and colleagues’ critical editorial.
Novartis reach provisional agreement on Glivec
(2 pages, 38 KB)
2002/10/02
PHARMAC has reached a provisional agreement with Novartis to fund the cancer drug Glivec for a wide group of New Zealanders. PHARMAC is asking for submissions on its funding proposal, which involves a number of products and is subject to the outcome of consultation and final approval by the PHARMAC Board.
Schering proposal involving Mirena, Nova-T, Prognova and Nuvelle
(3 pages, 15 KB)
2002/08/05
PHARMAC has signed a provisional agreement with Schering (NZ) dated 19 July 2002 regarding…
Annual Report - year ended 30 June 2001
(36 pages, 84 KB)
2002/07/30
Inaugural report of Pharmaceutical Management Agency for the six month period ended 30 June 2001.
PHARMAC Annual Plan 2001-2002
(39 pages, 539 KB)
2002/07/26
PHARMAC’s Objective PHARMAC’s overall objective, as outlined in s.47 (a) the New Zealand Public Health and Disability (NZPHD) Act 2000 is: to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided. This Plan outlines PHARMAC’s objectives for the 2001/02 year.
PHARMAC Business Plan 2000-2001
(78 pages, 247 KB)
2002/07/26
The theme for 2000-01 is the further development of the supply side tools for the management of expenditure and the development of the Demand Side. These initiatives will continue to support PHARMAC’s goal of optimising the Government’s expenditure on pharmaceutical subsidies.
National Hospital Pharmaceutical Strategy
(64 pages, 172 KB)
2002/07/19
National Hospital Pharmaceutical Strategy Final Version Pharmaceutical Management Agency 1 February 2002 M16-3-8 #61114 1 Table of Contents Executive Summary 1.0 Introduction 2.0 Current Market Overview 2.1 Current purchasing arrangements 2.2 Range of pharmaceuticals purchased 2.3 Data collection and analysis…
Schedule Update - effective 1 August 2002
(48 pages, 390 KB)
2002/07/18
Pharmaceutical Management Agency, New Zealand. Pharmaceutical Schedule UPDATE Effective 1 August 2002. Cumulative Update for May, June, July & August 2002.
